Asia-Pacific Pharmaceutical Co., Ltd.: Planning for changes in company ownership control, stock trading suspension

Asia-Pacific Pharmaceutical announced that on September 26th, the company received a notice from the controlling shareholder Ningbo Fubon Holdings Group Co., Ltd., the concerted action Shanghai Hangui Investment Management Co., Ltd., the actual controller Song Hanping, Fu Cai, and Hu Zhenghui management team, and the concerted actioner Song Lingjie that they are planning to change the company's control rights. The specific transaction plan, agreement terms, etc. still need further consultation and negotiation, and at present, the parties involved have not yet signed a formal transaction agreement. The above-mentioned may result in a change of the company's controlling shareholder and actual controller. The company's stock will be suspended from trading starting on September 29, 2025, and the suspension is expected to last no more than two trading days.